CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 254 filers reported holding CRISPR THERAPEUTICS AG in Q4 2019. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,003,428 | +2289.1% | 22,185 | +6386.8% | 0.03% | +1250.0% |
Q1 2021 | $42,000 | -8.7% | 342 | +12.9% | 0.00% | 0.0% |
Q4 2020 | $46,000 | -90.1% | 303 | -94.6% | 0.00% | -92.3% |
Q3 2020 | $467,000 | +54.6% | 5,588 | +35.9% | 0.03% | -48.0% |
Q2 2020 | $302,000 | +231.9% | 4,111 | +91.4% | 0.05% | +2.0% |
Q1 2020 | $91,000 | +68.5% | 2,148 | +140.3% | 0.05% | +345.5% |
Q4 2019 | $54,000 | – | 894 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |